Real-time enrollment status for this hematologic malignancies clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:49 PM UTC
| NCT Number | NCT04728893 |
| Recruiting Status | Recruiting |
| Condition | Hematologic Malignancies |
| Phase | PHASE2 |
| Target Enrollment | 490 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | October 15, 2026 (17 hours ago) |
As of October 15, 2026: Clinical trial NCT04728893 is currently recruiting participants. This phase2 study for hematologic malignancies is actively seeking new participants at 11 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04728893 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04728893 was last updated 17 hours ago (October 15, 2026). HelloStudys verifies this status automatically.